GRAIL, Inc.

GRAIL Reports Third Quarter 2026 Financial Results

FDA Advisory Committee Voted in Favor of Approval of GRAIL's Galleri Multi-Cancer Early Detection Test Q3 Galleri®Test Volume Increased ~24% to More…